﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Pharmaceutical Sciences</JournalTitle>
      <Issn>1735-403X</Issn>
      <Volume>26</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2020</Year>
        <Month>12</Month>
        <DAY>25</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Evaluation of the Effects of Human Beta-Interferon Scaffold Attachment Region (IFN-SAR) on Expression of Vascular Endothelial Growth Factor-Fc (VEGF-Fc) Fusion Protein Expression in Chinese Hamster Ovary (CHO) Cells</ArticleTitle>
    <FirstPage>393</FirstPage>
    <LastPage>398</LastPage>
    <ELocationID EIdType="doi">10.34172/PS.2020.37</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ehsan</FirstName>
        <LastName>Naghneh</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0780-0257</Identifier>
      </Author>
      <Author>
        <FirstName>Es'hagh</FirstName>
        <LastName>Pourmaleki</LastName>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Rahimpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3296-5881</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/PS.2020.37</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>05</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <Abstract>Background: Recombinant anti-vascular endothelial growth factor (VEGF) monoclonal antibodies and Fc-fusion proteins have been widely used for the effective treatment of retinal neovascular diseases. In this regard, VEGFR-Fc fusions, which act as strong VEGF inhibitors, have been approved for the treatment of age-related macular degeneration (AMD) and diabetic macular edema (DME). Production of monoclonal antibodies and Fc-fusion proteins relies on mammalian host systems such as Chinese hamster ovary (CHO) cells. Application of genomic regulatory elements including scaffold/matrix attachment regions (SAR/MARs) can profoundly affect recombinant protein expression in CHO cells. Methods: To construct the VEGFR-Fc expression vectors, the enhanced green fluorescent protein (EGFP) gene was replaced by the VEGFR-Fc coding sequence in pEGFP-SAR-puro and pEGFP-puro vectors. Recombinant plasmids were transfected to CHO-K1 cells using TurboFect transfection reagent. VEGFR-Fc expression was evaluated in transiently transfected cells as well as stable cell pools and clones using an enzyme-linked immunosorbent assay (ELISA). Results: IFN-SAR showed no significant effect on transient expression of VEGFR-Fc during 72 h of culture. However, a 2.2-fold enhancement in VEGFR-Fc fusion protein titer was observed in IFN-SAR containing stable cell pools. Further evaluation of the VEGFR-Fc expression level in single-cell clones also indicated that clones with the highest VEGFR-Fc expression belonged to the pools transfected with IFN-SAR construct. Conclusion: Our results indicate that the incorporation of IFN-SAR in expression vector can increase the expression of VEGFR-Fc in stable cell pools as well as single-cell clones. In contrast, transient expression of the fusion protein was not affected by IFN-SAR. More studies are needed to investigate the mechanism underlying this effect, including the analysis of mRNA expression and gene copy number in stable cell pools as well as clonal cells.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Chinese hamster ovary cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Fusion protein</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Scaffold/matrix attachment region</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Vascular endothelial growth factor receptor</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>